SNDK
Sandisk Corporation
SNDK has the edge over VRSN overall, supported by stronger fundamentals and stronger modeled upside.
VRSN
VeriSign, Inc.
VRSN has lower modeled downside risk, despite its lower overall score.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
VRSN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
VRSN's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over VRSN in the historical PE scenario, which offers more potential upside but is not a forecast.
VRSN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $228 | -27% |
| Forward | 29x | $312 | — |
| Fair | 30x | $282 | -9.6% |
| Current | 34x | $312 | — |
| Expensive | 35x | $326 | +4.3% |
Historical ranges are pointers, not guarantees.
VRSN's PE is in its expensive range at 34x. If earnings grow as analysts expect, today's price would be 29x next year's earnings, in its fair range.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
VRSN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for VRSN, with profitability improving.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over VRSN in the latest year-over-year earnings comparison.
VRSN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.86 | +17% |
| Q3 2026 | $9.30 | +8.4% |
| Q2 2026 | $9.22 | +10% |
| Q1 2026 | $9.05 | +11% |
| Q4 2025 | $8.81 | +10% |
| Q3 2025 | $8.58 | 0% |
| Q2 2025 | $8.38 | +0.5% |
| Q1 2025 | $8.18 | +0.7% |
| Q4 2024 | $8.00 | +1.3% |
VRSN earned $9.30 per share over the past year, up 8.4% from the year before.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over VRSN on profitability, with a higher operating margin.
VRSN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $443M | +5.7% |
| Q2 2026 | $434.6M | +6% |
| Q1 2026 | $428.9M | +6.6% |
| Q4 2025 | $425.3M | +7.6% |
| Q3 2025 | $419.1M | +7.3% |
| Q2 2025 | $409.9M | +5.9% |
| Q1 2025 | $402.3M | +4.7% |
| Q4 2024 | $395.4M | +3.9% |
VRSN's revenue has grown year over year every quarter since late 2020: $443M last quarter, up 5.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 67% | -0.9 points |
| Q2 2026 | 68% | -0.3 points |
| Q1 2026 | 68% | +1 points |
| Q4 2025 | 67% | +0.2 points |
| Q3 2025 | 68% | -1.1 points |
| Q2 2025 | 68% | -0.3 points |
| Q1 2025 | 67% | 0 points |
| Q4 2024 | 67% | -0.7 points |
VRSN's operating margin was 67% last quarter, down 0.9 points from the same quarter a year ago.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over VRSN on cash flow, with more consistent year-over-year improvement.
VRSN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $260.7M | -14% |
| Q2 2026 | $212.8M | +9.3% |
| Q1 2026 | $265.2M | -7.1% |
| Q4 2025 | $285.1M | +28% |
| Q3 2025 | $303M | +22% |
| Q2 2025 | $194.7M | +29% |
| Q1 2025 | $285.5M | +13% |
| Q4 2024 | $222M | +11% |
VRSN's free cash flow has been positive every quarter for six years: $1B over the past year, up 1.9% from the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
VRSN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -700K shares |
| 1 year | -3.4% | -3.2M shares |
| 3 years | -12% | -12.6M shares |
| 5 years | -19% | -21.4M shares |
| Available history | -24% | -28.6M shares |
VRSN has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $193.2M |
| Q2 2026 | $201.4M |
| Q1 2026 | $225.4M |
| Q4 2025 | $254.4M |
| Q3 2025 | $218.7M |
| Q2 2025 | $166.8M |
| Q1 2025 | $241.7M |
| Q4 2024 | $262.3M |
VRSN spent $874M buying back its own shares over the past year, down 1.7% from the year before.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over VRSN on leverage, with a lower net debt burden relative to earnings.
VRSN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | 1.5x | Healthy |
VRSN has more cash than debt.
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
VRSN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.5 | Neutral |
| Stochastic | 78.0 | Neutral |
VRSN's weekly RSI is 64 (neutral) and its Stochastic is 78 (neutral).
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over VRSN on valuation relative to its sector.
VRSN PE vs Technology Sector
| Metric | VRSN | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 28x | 21% above |
| PE % | 74 | 35 | 39 pts above |
VRSN is trading at 34x earnings, a 21% premium to the Technology sector's median of 28x.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
VRSN has stronger trend alignment. SNDK is above 0 of 3 weekly averages versus VRSN above 5 of 5.
VRSN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $301.3 | 3.7% above |
| 20 week MA | $291.3 | 7.3% above |
| 50 week MA | $270.2 | 16% above |
| 100 week MA | $263.2 | 19% above |
| 200 week MA | $230.6 | 36% above |
VRSN is in an uptrend: it's above all five of its weekly moving averages, and 36% above its 200-week average.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over VRSN on returns for 2026, with the stronger performance.
VRSN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $194.1 | $214.6 | +11% |
| 2021 | $214.6 | $249.6 | +16% |
| 2022 | $249.6 | $203.7 | -18% |
| 2023 | $203.7 | $206.0 | +1.1% |
| 2024 | $206.0 | $204.0 | -1% |
| 2025 | $204.0 | $246.3 | +21% |
| 2026 YTD | $246.3 | $312.5 | +27% |
VRSN has finished higher in four of the last six years. It's up 27% so far in 2026.